# Intestinal and Humoral Immunity of Sequential Polio Vaccination Schedules

> **NCT02412514** · PHASE4 · COMPLETED · sponsor: **Centers for Disease Control and Prevention** · enrollment: 456 (actual)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** bOPV (three dose)
- **BIOLOGICAL:** bOPV (two dose)
- **BIOLOGICAL:** IPV

## Key facts

- **NCT ID:** NCT02412514
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 456 (ACTUAL)
- **Last updated:** 2016-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02412514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02412514, "Intestinal and Humoral Immunity of Sequential Polio Vaccination Schedules". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02412514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*